Therefore, if modulation of caspase-8 function via Src inhibition is to be exploited in the treatment of human carcinomas, care must be taken when choosing appropriate pre-clinical model systems to explore new therapeutic agents. The gene discussed is CASP8; the disease is carcinoma.